-
公开(公告)号：US4206481A
公开(公告)日：1980-06-03
申请号：US870527
申请日：1978-01-18
CPC分类号： H01J29/826 , H01J29/762
摘要： A front extended portion, a pair of facing extending segments, and a rear extended portion mounted on the extending segments, which compose a coil separator, are integrally molded. Saddle-type horizontal coil is inserted in a rear extended portion through an opening between the pair of facing extending segments. In this state the horizontal coil are fixed to the rear extended portion of the coil separator by means of spacers.
摘要翻译： 整体模制了前延伸部分，一对相对的延伸段和安装在延伸段上的后延伸部分，其构成线圈分离器。 鞍形水平线圈通过一对相对的延伸段之间的开口插入到后延伸部分中。 在这种状态下，水平线圈通过间隔件固定到线圈分离器的后延伸部分。
-
2.发明授权Morphan derivatives or salts thereof and medicinal compositions containing the same 失效莫衍生物或其盐和含有它们的药物组合物公开(公告)号：US06608080B1
公开(公告)日：2003-08-19
申请号：US09913666
申请日：2001-08-16
IPC分类号： A61K31439
CPC分类号： C07D221/22 , C07D471/10
摘要： Medicinal compositions having an effect of regulating the activation of glycine receptor and novel morphan derivatives. Medicinal compositions comprising morphan derivatives or its salts and a pharmaceutically acceptable carrier. These compositions potentiate or inhibit the activation of glycine receptor, which makes them useful as drugs for the central nervous system. Novel 1- and/or 2-substituted morphan derivatives (2-azabicyclo[3.3.1]nonane derivatives) or salts thereof.
摘要翻译： 具有调节甘氨酸受体活化和新型morphan衍生物的作用的药用组合物。 药物组合物，其包含芴衍生物或其盐和药学上可接受的载体。 这些组合物增强或抑制甘氨酸受体的活化，这使得它们可用作中枢神经系统的药物。 新颖的1-和/或2-取代的吗啉衍生物（2-氮杂双环[3.3.1]壬烷衍生物）或其盐。
-
公开(公告)号：US20120225818A1
公开(公告)日：2012-09-06
申请号：US13389215
申请日：2010-08-05
申请人： Shintaro Kamei , Asami Shindome , Takayoshi Hamamoto , Hiroaki Maeda , Masaki Hirashima , Sachio Okuda , Misako Umehashi , Sachie Ogawa , Megumi Imuta , Norio Akaike , Kazuo Takahama , Ryoko Wada
发明人： Shintaro Kamei , Asami Shindome , Takayoshi Hamamoto , Hiroaki Maeda , Masaki Hirashima , Sachio Okuda , Misako Umehashi , Sachie Ogawa , Megumi Imuta , Norio Akaike , Kazuo Takahama , Ryoko Wada
CPC分类号： C12N9/6443 , A61K38/4846
摘要： The activated Factor XI is provided as an antitussive for cough caused by the stimulation at the tracheal bifurcation such as chronic cough. A pharmaceutical composition for prevention, treatment and/or symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier, wherein the polypeptide chain consists of a full length amino acid sequence constituting activated Factor XI (hereinafter also referred to as “FXIa”), the amino acid sequence with one or several amino acids therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences.
摘要翻译： 提供活化因子XI作为由气管分叉如慢性咳嗽引起的咳嗽的镇咳药。 一种用于预防，治疗和/或症状改善咳嗽的药物组合物，其包含多肽链作为活性成分和药学上可接受的载体，其中所述多肽链由构成活化因子XI的全长氨基酸序列组成（以下也称为 作为“FXIa”），其中具有一个或几个氨基酸的氨基酸序列被缺失，取代或加入，或任一上述氨基酸序列的部分序列，或包含上述任何一种的氨基酸序列 氨基酸序列。
-
4.发明授权
公开(公告)号：US5177062A
公开(公告)日：1993-01-05
申请号：US325649
申请日：1989-03-20
申请人： Takeshi Miyata , Kazuo Takahama , Hirofumi Kai , Takayuki Ishii , Keiji Komatsu
发明人： Takeshi Miyata , Kazuo Takahama , Hirofumi Kai , Takayuki Ishii , Keiji Komatsu
IPC分类号： A61K31/70
CPC分类号： A61K31/7004
摘要： A preparation for treating immune complex diseases which comprises injection containing the following compound: ##STR1## wherein when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharmacologically acceptable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous.
摘要翻译： 一种用于治疗免疫复合物疾病的制剂，其包含含有以下化合物的注射剂：其中当n为1时，Z表示氢，锂，钾，钠，铵或有机铵，当n为2时，Z表示钙， 钡或镁，作为活性成分和药理学上可接受的载体。 本发明的制剂可以以任何施用方法如皮下注射，肌内注射和静脉内使用。
-
-
-
搜索结果
4 条记录 (耗时 0.021 秒)
